Tag: drug_safety

• Fresenius Kabi Recalls Tyenne® Injection Vials Due to Glass Particles

  12 Aug 2026 4:47 p.m. · Source: US Food and Drug Administration

  Fresenius Kabi is recalling Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL vials nationwide due to glass particles, posing risks including blood clots and organ damage. The affected lot was shipped between March 3 and March 25, 2026.

  HealthBusinessMedical ScienceLegalEconomy Product RecallPharmaceuticalsFresenius KabiTyenneTocilizumab-aazgGlass ParticlesDrug SafetyFood RecallsFDADrugs

• Fresenius Kabi Recalls Tyenne Injection Vials Due to Glass Particles

  12 Aug 2026 8:32 a.m. · Source: US Food and Drug Administration

  Fresenius Kabi has issued a nationwide recall for one lot of Tyenne Injection 400 mg/20 mL vials. The recall is due to the presence of glass particles, posing serious health risks including blood clots and organ damage.

  HealthBusinessMedical ScienceFederal Government Fresenius KabiTyenne InjectionProduct RecallGlass ParticlesFDADrug SafetyPharmaceuticalsFood RecallsDrugs

• Fresenius Kabi Recalls Morphine Syringes Over Dilaudid Labeling Mix-up

  10 Aug 2026 2:35 p.m. · Source: US Food and Drug Administration

  Fresenius Kabi has initiated a nationwide recall for one lot of Morphine Sulfate Injection, USP, Simplist® 2 mg/1 mL. The recall is due to a labeling error where MicroVaults may contain Dilaudid 0.5 mg/0.5 mL, posing serious health risks.

  HealthBusinessMedical ScienceSocial IssuesLegal Fresenius KabiMorphine Sulfate InjectionDilaudidProduct RecallLabeling ErrorDrug SafetyPharmaceuticalsFood RecallsFDADrugs

• American Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter

  27 Jul 2026 3:53 p.m. · Source: US Food and Drug Administration

  American Regent, Inc. has issued a nationwide voluntary recall for a lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL. The recall is due to particulate matter, including glass, posing risks like stroke or death, though no adverse events are…

  HealthBusinessMedical ScienceLegalFederal GovernmentSocial Issues Product RecallPapaverine HydrochlorideAmerican RegentDrug SafetyParticulate MatterInjectionPharmaceuticalsFood RecallsFDADrugs

• Library of Congress Reveals Most-Viewed Bills for Late June 2026

  22 Jun 2026 8:48 a.m. · Source: U.S. Library of Congress

  The Library of Congress released its most-viewed bills for the week of June 21, 2026, featuring key legislation on obesity, drug safety, digital assets, national defense, veterans' care, and housing, reflecting diverse public and congressional interest.

  Politics and GovernmentHealthBusinessFederal GovernmentCongressMedical ScienceEconomyMilitarySocial Issues Library of CongressLegislationObesityDrug SafetyDigital AssetsNational DefenseVeteransU.S. Library of Congress

• FDA Warns Against Use of Recalled Bupivacaine Injections from Huons Co., Ltd.

  12 Jun 2026 1:31 p.m. · Source: US Food and Drug Administration

  Huons Co., Ltd. has recalled Bupivacaine Hydrochloride in Dextrose Injection, USP, due to quality issues. Medline advises customers to remove these injections from convenience kits, as their use poses risks of infection, inflammation, and severe neurological complications.

  HealthBusinessPolitics and GovernmentMedical ScienceFederal GovernmentLegalGeneral Politics Bupivacaine HydrochlorideHuons Co., Ltd.MedlineFDAProduct RecallMedical DevicesDrug SafetyFood RecallsDrugs

• FDA Approves New Kidney Risk Warnings for OTC Weight Loss Drug alli

  10 Jun 2026 1:18 p.m. · Source: US Food and Drug Administration

  The FDA has approved new labeling for the OTC weight loss drug alli (orlistat) 60 mg, warning of rare risks including acute kidney injury and kidney stones. Consumers with a history of kidney issues should consult a doctor before use.

  HealthPolitics and GovernmentMedical ScienceFederal GovernmentEducation FDAalliorlistatkidney injurykidney stonesweight lossDrug SafetyFood RecallsDrugs

← Back to latest